REACH
Phase NA Recruiting
257 enrolled
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Phase 1 Recruiting
42 enrolled
ELEPHAS-04
Recruiting
324 enrolled
GENCONCOR-2
Recruiting
30 enrolled
HEARTS Trial for Thoracic Cancers
Phase 2 Recruiting
60 enrolled
PEGASUS
Phase 2 Recruiting
30 enrolled
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)
Recruiting
1,500 enrolled
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
4,000 enrolled
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Phase 4 Recruiting
22 enrolled
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 Recruiting
40 enrolled
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Recruiting
5,000 enrolled
MOMENTUM
Recruiting
8,000 enrolled
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 Recruiting
60 enrolled
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Phase NA Recruiting
600 enrolled
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
22 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Recruiting
80 enrolled
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Recruiting
60 enrolled
MAGECmultiDiCE
Phase NA Recruiting
2,200 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
MAGEC
Phase NA Recruiting
1,000 enrolled
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Phase NA Recruiting
20 enrolled
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
VISTA
Phase 1 Recruiting
45 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
OPTIMUS
Phase NA Recruiting
50 enrolled
POISE
Phase 3 Recruiting
20 enrolled
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2 Recruiting
49 enrolled
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase NA Recruiting
1,550 enrolled
iCaRe2
Recruiting
999,999 enrolled
SCR-ESCC-01
Phase 2 Recruiting
100 enrolled
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 Recruiting
2,000 enrolled
Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 Recruiting
2,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Precision Palliative Care for Patients With Advanced Esophageal Cancer
Recruiting
624 enrolled
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
Phase NA Recruiting
20 enrolled
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Phase 2 Recruiting
38 enrolled
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Phase 3 Recruiting
432 enrolled
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
Phase 2 Recruiting
52 enrolled
ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients
Recruiting
700 enrolled
Target-specific immunoPET Imaging of Digestive System Carcinoma
Phase NA Recruiting
400 enrolled
Shanghai Clinical Cohort - Esophageal Cancer
Recruiting
2,116 enrolled
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
Recruiting
56 enrolled
TNT-OES-2
Phase 2 Recruiting
216 enrolled
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Phase 1 Recruiting
20 enrolled
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Recruiting
100 enrolled
PaRCUS
Phase 2 Recruiting
50 enrolled
EsophaCap for the Detection of Early Esophageal Carcinoma
Recruiting
2,500 enrolled